sábado, 4 de enero de 2025

Neumora’s antidepressant stumbles in first Phase 3 trial readout The company says the data were disappointing but include positive trends

https://www.statnews.com/2025/01/02/neumora-therapeutics-antidepressant-clinical-trial-data/?utm_campaign=daily_recap&utm_medium=email&_hsenc=p2ANqtz--Ac3BCpMG3A0jO7vIpq9FszL8CtHQPngM35xfKYIyna6N9a9tj198FTPjKywFLTzDwFA11cCWQYU1tLiQynGMFF1NjUQ&_hsmi=340862397&utm_content=340862397&utm_source=hs_email

No hay comentarios: